APOL1 and kidney disorder: Genetic analysis of 5,727 patients with kidney disease from 3 diverse cohorts identified 371 patients (6.5%) with monogenic kidney disorders, 318 (5.5%) with high-risk APOL1 genotypes, and 100 (5.2%) in CureGN with ACMG SFs.